Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

[Download PDF
Year : 2004  |  Volume : 50  |  Issue : 4  |  Page : 270-271  

Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia

Georgios G Trimis1, CK Athanassaki1, MM Kanariou2, AA Giannoulia-Karantana1,  
1 Pediatric Department of University of Athens, Greece
2 Department of Immunology, Childrenís Hospital Agia Sophia, Athens, Greece

Correspondence Address:
Georgios G Trimis
Pediatric Department of University of Athens


Ataxia-telangiectasia (A-T) is a rare multisystem, neurodegenerative genetic disorder. We present a case of a 6-year-old girl who had a history of frequent respiratory infections and also had ocular and immunological features of this syndrome. The absence of neurological symptoms, which is very unusual for a patient of this age, raised many difficulties in the diagnosis of the disease. It is concluded that a normal neurological assessment must not exclude the diagnosis of A-T and delay the proper interventional measures.

How to cite this article:
Trimis GG, Athanassaki C K, Kanariou M M, Giannoulia-Karantana A A. Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia .J Postgrad Med 2004;50:270-271

How to cite this URL:
Trimis GG, Athanassaki C K, Kanariou M M, Giannoulia-Karantana A A. Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia . J Postgrad Med [serial online] 2004 [cited 2020 Dec 6 ];50:270-271
Available from:

Full Text

Ataxia-telangiectasia (A-T) is a rare multisystem disorder. Most affected individuals require the use of a wheelchair during late childhood or adolescence and survive only to early adulthood.[1] The main features of A-T are progressive cerebellar ataxia, oculocutaneous telangiectasias and chronic sinopulmonary infections.[2],[3] Here we describe a case of A-T who did not have any neurological symptoms.

 Case History

A 6-year-old girl was referred to our department for further evaluation because she had been suffering from bronchitis since one month, which did not improve, despite therapy with bronchodilators and antibiotics. Her maternal grandmother and aunt had died from breast cancer, while her paternal grandfather had died from pancreatic cancer. The patient had no perinatal problems and her developmental milestones were normal. She had recurrent nasal infections and two episodes of bronchitis, which were treated with antibiotics. She showed improvement, but there was no resolution. She was coughing occasionally when drinking liquids.

On physical examination, the girl had no peripheral cyanosis or clubbing (SATO2: 97%). She was normocephalic, weight and height were between the third and fifth percentile. There were obvious telangiectasias on the bulbar conjunctiva bilaterally. She had purulent nasal discharge and some rales bilaterally without wheezing. Neurological assessment was normal. She had normal eye movements, normal cranial nerve examination, normal strength, muscle tone and tests of cerebellar function.

The girl was hospitalised and treated with intravenous antibiotics and bronchodilators for almost two months, with a very slow resolution of symptoms. A variety of diagnostic studies were performed. The patient had lymphopenia: WBC was normal (6500/mm3) but she had only 13% lymphocytes (absolute count 850/mm3). She also had low serum levels of IgA (T). The patient was started on prophylactic infusions of IVIG 400 mg /kg every three weeks, cefaclor 20 mg/kg and fluticasone 50 mcg once daily. A cine-oesophagopharyngogram showed oropharyngeal dysfunction in swallowing.


The diagnosis of A-T syndrome is established in patients over one year of age who show ataxia or significant motor incoordination with a serum level of AFP more than twice the upper limit of normal. Patients are also required to fulfil three of the following four criteria: (1) incoordination of the head and eyes in lateral gaze deflection; (2) ocular or cutaneous telangiectasias before the age of five years; (3) gait ataxia; and (4) lymphopenia, especially of CD4, and immunoglobulin deficiencies, mainly of IgA and/or IgG subclasses.[4] Patients with less than three of these criteria should have the diagnosis confirmed by the finding of radiation-induced chromosomal breaks in lymphocytes and low ability of repairing them.[1] The molecular study of the ATM gene that has been cloned to the long arm of Chromosome 11 (11q22-23) confirms the diagnosis. Very few patients with A-T have been described with late onset disease and/or survival into the 4th decade. Other immunodeficiency disorders or multisystemic diseases (e.g. cystic fibrosis) must be differentiated in the absence of neurological symptoms. Patients homozygous for a single truncating mutation have a more aggressive clinical phenotype than those with splice site alterations or a missense mutation. However, the splice site alteration 8850G>T of the ATM gene that has been detected in our patient, was found also in an Italian boy who had the typical clinical picture of the disease.[2]

Our patient had fulfilled two of the A-T criteria, but the absence of involvement of the neurological system was responsible for the delay of the A-T syndrome diagnosis. The A-T syndrome usually affects cerebellar function progressively from the second year of age. Speech becomes dysarthric, movements are awkward and slow. Patients with the A-T syndrome lose the ability of maintaining balance, ability to read and write due to progressive neurodegeneration.[5] On the contrary, our patient at age 6 had normal motor activities, normal speech development and she had learnt to write a few words. An unusual persistent episode of bronchitis, which did not improve, despite therapy with bronchodilators and antibiotics, was the cause of the referral to a tertiary centre, where the diagnosis was established after extensive laboratory studies.

Prompt diagnosis of the A-T syndrome was important because, apart from early administration of prophylactic treatment, it helped in the detection of oropharyngeal dysfunction. The defect in DNA repair puts our patient at risk of chromosomal damage and therefore lymphoreticular malignancy from exposure to X-rays.[6],[7] Heterozygotes of the A-‘ gene also have the same defect, that's why many members of the patient's family suffered from cancer.[8] Oropharyngeal dysphagia predisposes to microaspirations. Our patient should be encouraged to eat frequently, small amounts of food with high caloric density and nutritional value that do not require a great deal of chewing.[9]

The prognosis in our report is likely to be unfavourable, although the neurological course of the disease remains mild until now.[1],[10] Respiratory insufficiency due to bronchiectasias from recurrent infections is the leading cause of death. The frequency of neoplasms is very high. The patients usually survive only into the late teens or twenties, although some affected individuals have reportedly survived into the sixth decade. There is no cure or medical treatment for this disease.

In summary, A-T syndrome is a multisystem disorder that affects mainly the brain and the immune system, with no cure, and with unfavourable prognosis. There is accumulating evidence to assume that some mutations conferring residual ATM activity are associated with an attenuated clinical phenotype. Subsequently, a normal neurological assessment must not exclude the diagnosis of A-T and delay the proper interventional measures.


1Perlman S, Becker-Catania S, Gatti RA. Ataxia-telangiectasia: Diagnosis and treatment. Semin Pediatr Neurol 2003;10:173-82.
2Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 2000;92:170-7.
3Fanos JH, Mackintosh MA. Never again joy without sorrow: The effect on parents of a child with ataxia-telangiectasia. Am J Med Genet 1999;87:413-9.
4Schubert R, Reichenbach J, Zielen S. Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia. Clin Exp Immunol 2002;129:125-32.
5Crawford TO, Mandir AS, Lefton-Greif MA, Goodman SN, Goodman BK, Sengul H, et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000;54:1505-9.
6Kutluk MT, Yalcin B, Buyukpamukcu M. Ataxia telangiectasia and Hodgkin disease. Med Pediatr Oncol 2000;35:509.
7Neubauer S, Arutyunyan R, Stumm M, Dork T, Bendix R, Bremer M, et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat Res 2002;157:312-21.
8Geoffroy-Perez B, Janin N, Ossian K, Lauge A, Croquette MF, Griscelli C, et al. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 2001;93:288-93.
9Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 2000;136:225-31.
10Irsfeld H, Korholz D, Janssen G, Wahn V, Schroten H. Fatal outcome in two girls with Hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy. Med Pediatr Oncol 2000;34:62-4.

Sunday, December 6, 2020
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer